Skip to main content
Premium Trial:

Request an Annual Quote

DOE Awards Genomatica $2M to Apply In Silico Tech to Two Microorganisms

NEW YORK, Jan. 3 - The US Department of Energy has awarded Genomatica a pair of grants worth more than $2 million to help it develop next-generation in silico technology, Genomatica said on Thursday.


The grants, awarded through the DOE's Offices of Advanced Scientific Computing Research and Biological and Environmental Research of the Office of Science, will be doled out over the next three years.


Through the grants, Genomatica intends to use constraints-based modeling to develop integrated models of metabolism and metabolic regulation for two undisclosed microorganisms "of environmental relevance." It will build these models, as well as develop future technology, in collaborations with Penn State University, The University of Massachusetts, and Oak Ridge National Laboratory.


"The advanced constraints-based modeling technology used and further developed under these grants will play an important role in the company's program to develop its next-generation microbial models," Genomatica said in a statement.


"The research performed under these grants will lead to the use of current in silico models to solve pressing problems and allow us to develop second generation genome-scale cellular models," added Bernhard O. Palsson, chairman and acting CEO of Genomatica.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.